ALPHATEC HOLDINGS, INC. Increase (Decrease) in Accrued Liabilities
ALPHATEC HOLDINGS, INC. (ATEC) reported Increase (Decrease) in Accrued Liabilities of -$6.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-04
- ALPHATEC HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$17.81M.
- ALPHATEC HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $11.20M, a 19.62% decline year-over-year.
- ALPHATEC HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$3.49M, a 154.35% decline year-over-year.
- ALPHATEC HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $14.64M, a 491.63% increase year-over-year.
- ALPHATEC HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $15.82M.
- ALPHATEC HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2024 was -$1.78M, a 110.48% decline from fiscal 2023.
- ALPHATEC HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $17.00M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$17.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$6.61M 10-Q · filed 2026-08-04 | -$10.10M derived: sum of 3 quarters · filed 2026-08-04 | $4.54M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $11.20M 10-Q · filed 2026-05-05 | $7.71M derived: sum of 2 quarters · filed 2026-05-05 | $22.35M derived: sum of 3 quarters · filed 2026-05-05 | $13.09M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $11.15M derived: sum of 2 quarters · filed 2026-02-24 | $1.89M derived: sum of 3 quarters · filed 2026-08-04 | $15.82M 10-K · filed 2026-02-24 |
| 2025-09-30 | $14.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.38M derived: sum of 2 quarters · filed 2026-08-04 | $19.31M 10-Q · filed 2025-10-30 | $25.73M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$9.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $4.68M 10-Q · filed 2026-08-04 | $11.10M derived: sum of 3 quarters · filed 2026-08-04 | $13.57M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $13.94M 10-Q · filed 2026-05-05 | $20.36M derived: sum of 2 quarters · filed 2026-05-05 | $22.83M derived: sum of 3 quarters · filed 2026-05-05 | $14.71M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $8.89M derived: sum of 2 quarters · filed 2026-02-24 | $770.00K derived: sum of 3 quarters · filed 2026-02-24 | -$1.78M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$5.65M derived: sum of 2 quarters · filed 2025-10-30 | -$8.20M 10-Q · filed 2025-10-30 | $814.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$8.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$10.68M 10-Q · filed 2025-07-31 | -$1.66M derived: sum of 3 quarters · filed 2026-02-24 | $1.96M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$2.55M 10-Q · filed 2025-05-01 | $6.46M derived: sum of 2 quarters · filed 2026-02-24 | $10.09M derived: sum of 3 quarters · filed 2026-02-24 | $15.15M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $12.64M derived: sum of 2 quarters · filed 2026-02-24 | $17.70M derived: sum of 3 quarters · filed 2026-02-24 | $17.00M 10-K · filed 2026-02-24 |
| 2023-09-30 | $3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $8.69M derived: sum of 2 quarters · filed 2024-10-30 | $7.98M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $4.36M 10-Q · filed 2024-07-31 | ||
| 2023-03-31 | -$705.00K 10-Q · filed 2024-05-07 | |||
| 2022-09-30 | $7.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $5.69M derived: sum of 2 quarters · filed 2023-11-06 | $4.14M 10-Q · filed 2023-11-06 | |
| 2022-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$3.65M 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$1.54M 10-Q · filed 2023-05-04 | |||
| 2021-09-30 | $320.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $258.00K 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | -$62.00K 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |